HPX and sickle cell disease: The heme scavenger protein hemopexin has been efficient in preventing hemolysis-mediated C3 deposition in kidneys in a mouse model of intravascular hemolysis and on endothelial cells in vitro (39), as well as in models of stasis in sickle cell disease (68) or other hemolytic conditions (69).